Reporter

Stephen B. Baylin, MD, a leading cancer researcher from the Johns Hopkins School of Medicine, described his trailblazing studies of cancer epigenetics last week during a Flexner Discovery Lecture.

Kevin Warren has been named senior director of Vanderbilt Environmental Health and Safety, effective Oct. 1. He fills the position vacated by Bob Wheaton, who retired in June.

People who quit smoking see their risk of cardiovascular disease immediately begin to drop, but it may take up to 16 years for their health to reach the level of someone who has never smoked, according to a new Vanderbilt study.

Research by Vanderbilt scientists suggests that it may be possible to prevent or even reverse pulmonary arterial hypertension, a rare, progressive disease characterized by narrowing of and high blood pressure in the small arteries of the lungs.

New epilepsy monitoring systems at Vanderbilt University Medical Center are providing neurologists better data for assessing adult and pediatric patients.

Lynne Maquat, PhD, recipient of the 2017 Vanderbilt Prize in Biomedical Science whose work has advanced our understanding of human gene expression, will deliver her Vanderbilt Prize lecture as part of the Flexner Discovery Lecture series on Nov. 29.

David G. Harrison, MD, the Betty and Jack Bailey Professor of Cardiology and director of the Division of Clinical Pharmacology at Vanderbilt University School of Medicine, has been awarded the American Heart Association’s Basic Research Prize for 2018.